Philips showcases AI-enabled integrated solutions at ESC

At the European Society of Cardiology 2024 Congress in London, Royal Philips shared the next dimension in echocardiography, leveraging first-to-market AI-based capabilities that help accelerate and automate diagnosis of echocardiography measurements. The platform features AI tools designed to support the diagnosis of structural heart disease (SHD), including a new automated 3D tricuspid valve quantification tool and new 3D colour flow quantification to assist in diagnosing mitral regurgitation. Also featured was the VeriSight Pro real-time 3D intracardiac echocardiography catheter, designed to give physicians more control during a variety of minimally invasive procedures in SHD and electrophysiology. Additionally, Philips EchoNavigator, integrated with the Azurion image-guided therapy system, assists heart teams in treating complex SHD conditions, such as heart valve repair or replacement, with increased efficiency.

Making its debut was Philips’ latest AI-enabled cardiovascular ultrasound platform featuring applications designed to accelerate cardiac ultrasound analysis with proven technology. Now integrated with Philips Ultrasound Workspace, this platform enables the same diagnostic capabilities on and off-cart, allowing for advanced analysis of vendor-agnostic data to enhance confident decision making throughout the cardiology care path. AI-enabled Spectral CT 7500 offers advanced cardiac imaging with low dose technology and a reduction in time to diagnosis. Additionally, Philips CT 5300 features AI applications to increase productivity in diagnosis, interventional procedures, and screening, and meets the advanced diagnostic imaging requirements for cardiac care patient guidelines.

See this report on page 22 of the October 2024 issue of RAD Magazine.